| 11179359 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2021-11-23 |
$3,716,000 |
| 10722483 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2020-07-28 |
$10,782,000 |
| 10342770 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2019-07-09 |
$7,710,000 |
| 10188620 |
Treatment for NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2019-01-29 |
$7,161,000 |
| 10137112 |
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent |
Gopal Chandra Saha, Brian Edward Lavan, Charles A. McWherter |
2018-11-27 |
$7,375,000 |
| 10098843 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, Robert Martin, David Karpf, Douglas Alan Lorenz, Rodney James Ketner |
2018-10-16 |
$8,646,000 |
| 9962346 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2018-05-08 |
$9,590,000 |
| 9801860 |
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent |
Gopal Chandra Saha, Brian Edward Lavan, Charles A. McWherter |
2017-10-31 |
$7,190,000 |
| 9616039 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2017-04-11 |
$2,499,000 |
| 9439891 |
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent |
Gopal Chandra Saha, Brian Edward Lavan, Charles A. McWherter |
2016-09-13 |
$1,253,000 |
| 9433612 |
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent |
Gopal Chandra Saha, Brian Edward Lavan, Charles A. McWherter |
2016-09-06 |
$1,353,000 |
| 9381181 |
Treatment of NAFLD and NASH |
Xueyan Wang, Yun-Jung Choi, David Karpf, Robert Martin, Charles A. McWherter |
2016-07-05 |
$884,000 |
| 9241924 |
Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
Charles A. McWherter, Robert Martin, David Karpf, Douglas Alan Lorenz, Rodney James Ketner |
2016-01-26 |
$526,000 |
| 9060987 |
Methods for treating gout flares |
Brian Edward Lavan, Gopal Chandra Saha, Charles A. McWherter |
2015-06-23 |
$915,000 |
| 9023856 |
Methods for treating hyperuricemia in patients with gout using halofenate or halogenic acid and a second urate-lowering agent |
Gopal Chandra Saha, Brian Edward Lavan, Charles A. McWherter |
2015-05-05 |
$1,031,000 |